Cargando…
In silico study of medical decision-making for rare diseases: heterogeneity of decision-makers in a population improves overall benefit
BACKGROUND: Medical decision-making is difficult when information is limited due to its rareness. For example, there are two treatment options for patients affected by a rare disease with high lethality. The information about both treatment effects is unavailable or very limited. Patients are inclin...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
PeerJ Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161698/ https://www.ncbi.nlm.nih.gov/pubmed/30280044 http://dx.doi.org/10.7717/peerj.5677 |